122 related articles for article (PubMed ID: 28087480)
1. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
Ely LK; Truong M
J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.
Subramaniam A; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Obstet Gynecol; 2018 Jul; 132(1):20-27. PubMed ID: 29889762
[TBL] [Abstract][Full Text] [Related]
3. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study.
Rufin KGA; do Valle HA; McAlpine JN; Elwood C; Hanley GE
Fertil Steril; 2024 Mar; 121(3):531-539. PubMed ID: 38043843
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy between bilateral proximal tubal occlusion and total salpingectomy on ovarian reserve and the cholinergic system: an experimental study.
Atilgan R; Pala Ş; Kuloğlu T; Şanli C; Yavuzkir Ş; Özkan ZS
Turk J Med Sci; 2020 Jun; 50(4):1097-1105. PubMed ID: 32394684
[TBL] [Abstract][Full Text] [Related]
5. Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer.
Zadabedini Masouleh T; Etchegary H; Hodgkinson K; Wilson BJ; Dawson L
Curr Oncol; 2023 Nov; 30(12):10152-10165. PubMed ID: 38132373
[TBL] [Abstract][Full Text] [Related]
6. Risk of ovarian cancer after salpingectomy and tubal ligation: Prospects on histology and time since the procedure.
Duus AH; Zheng G; Baandrup L; Faber MT; Kjær SK
Gynecol Oncol; 2023 Oct; 177():125-131. PubMed ID: 37683548
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, Safety, and Provider Perspectives of Bipolar Electrosurgical Cautery Device for (Opportunistic or Complete) Salpingectomy at the Time of Cesarean Delivery.
Ostby SA; Blanchard CT; Sanjanwala AR; Szychowski JM; Leath CA; Huh WK; Subramaniam A
Am J Perinatol; 2024 Apr; 41(6):804-813. PubMed ID: 35728603
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.
Subramaniam A; Einerson BD; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Gynecol Oncol; 2019 Jan; 152(1):127-132. PubMed ID: 30477808
[TBL] [Abstract][Full Text] [Related]
9. Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis.
Kaur P; Rufin K; Finlayson SJ; Huntsman DG; Kwon JS; McAlpine JN; Miller DM; Hanley GE
J Obstet Gynaecol Can; 2024 Apr; 46(4):102278. PubMed ID: 37944815
[TBL] [Abstract][Full Text] [Related]
10. Complete Compared With Partial Salpingectomy for Postpartum Sterilization.
McCarley CB; Boitano TK; Dilley SE; Subramaniam A
Obstet Gynecol; 2023 Dec; 142(6):1347-1356. PubMed ID: 37884007
[TBL] [Abstract][Full Text] [Related]
11. Effect of salpingectomy versus tubal ligation on postoperative wound infection in patients: A meta-analysis.
Li M; Lv J
Int Wound J; 2024 Jan; 21(1):e14543. PubMed ID: 38272821
[TBL] [Abstract][Full Text] [Related]
12. Contraception and sterilization selection at delivery among pregnant patients with malignancy.
Harris CA; Mandelbaum RS; Rau AR; Song BB; Klar M; Ouzounian JG; Paulson RJ; Roman LD; Matsuo K
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):695-706. PubMed ID: 37578024
[TBL] [Abstract][Full Text] [Related]
13. Fallopian Tube Ligation or Salpingectomy as Means for Reducing Risk of Ovarian Cancer.
Szender JB; Lele SB
AMA J Ethics; 2015 Sep; 17(9):843-8. PubMed ID: 26390206
[No Abstract] [Full Text] [Related]
14. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.
Karia PS; Joshu CE; Visvanathan K
Cancer Prev Res (Phila); 2021 Dec; 14(12):1101-1110. PubMed ID: 34413116
[TBL] [Abstract][Full Text] [Related]
15. Racial Disparities in Sterilization Procedure Performed at Time of Cesarean Section.
Walheim LK; Hong CX; Hamm RF
Am J Perinatol; 2022 Dec; ():. PubMed ID: 36351447
[TBL] [Abstract][Full Text] [Related]
16. Salpingectomy and the Risk of Ovarian Cancer in Ontario.
Giannakeas V; Murji A; Lipscombe LL; Narod SA; Kotsopoulos J
JAMA Netw Open; 2023 Aug; 6(8):e2327198. PubMed ID: 37566421
[TBL] [Abstract][Full Text] [Related]
17. Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type.
Gaitskell K; Green J; Pirie K; Reeves G; Beral V;
Int J Cancer; 2016 Mar; 138(5):1076-84. PubMed ID: 26378908
[TBL] [Abstract][Full Text] [Related]
18. SALpingectomy for STERilisation (SALSTER): study protocol for a Swedish multicentre register-based randomised controlled trial.
Magarakis L; Idahl A; Sundfeldt K; Liv P; Pålsson M; Strandell A
BMJ Open; 2023 Sep; 13(9):e071246. PubMed ID: 37666548
[TBL] [Abstract][Full Text] [Related]
19. Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.
Kahn RM; Gordhandas S; Godwin K; Stone RL; Worley MJ; Lu KH; Long Roche KC
JAMA Surg; 2023 Nov; 158(11):1204-1211. PubMed ID: 37672283
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
